You are viewing an incomplete version of our website. Please click to reload the website as full version.

TNFRSF10C antibody (Tumor Necrosis Factor Receptor Superfamily, Member 10c, Decoy Without An Intracellular Domain)

Details for Product anti-TNFRSF10C Antibody No. ABIN499722, Supplier: Log in to see
Antigen
  • CD263
  • DCR1
  • DCR1-TNFR
  • LIT
  • TRAIL-R3
  • TRAILR3
  • TRID
  • TNFRSF10C
Alternatives
anti-Human TNFRSF10C antibody for Immunofluorescence
Reactivity
Human, Mouse (Murine), Rat (Rattus)
99
7
6
4
Host
Rabbit
60
40
4
3
Clonality
Polyclonal
Conjugate
This TNFRSF10C antibody is un-conjugated
17
12
1
1
1
1
1
1
Application
Enzyme Immunoassay (EIA), Immunofluorescence (IF), Western Blotting (WB)
57
52
18
15
7
5
2
2
2
2
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Available images

Immunogen Human DcR1 Peptide
Isotype IgG
Specificity DcR1 antibody was raised against a peptide corresponding to amino acids in the extracellular domain of human DcR1 precursor.
Purification Affinity chromatography purified via peptide column
Alternative Name CD263 / TRAILR3 (TNFRSF10C Antibody Abstract)
Background Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family and induces apoptosis of a variety of tumor cell lines. DR4 and DR5 are the recently identified functional receptors for TRAIL (1-3). Two decoy receptors for TRAIL have been identified and designated DcR1/TRID/TRAIL-R3/LIT (2-7) and DcR2/TRAIL-R4/TRUNDD (8-10). DcR1 has extracellular TRAIL-binding domain but lacks intracellular signaling domain. It is a glycophospholipid-anchored cell surface protein. DcR1 transcripts are expressed in many normal human tissues but not in most cancer cell lines. Overexpression of DcR1 did not induce apoptosis, but attenuated TRAIL-induced apoptosis.Synonyms: Antagonist decoy receptor for TRAIL/Apo-2L, DCR1, Decoy TRAIL receptor without death domain, Decoy receptor 1, LIT, Lymphocyte inhibitor of TRAIL, TNF-related apoptosis-inducing ligand receptor 3, TNFRSF10C, TRAIL receptor 3, TRAIL-R3, TRID, Trail receptor without an intracellular domain, Tumor necrosis factor receptor superfamily member 10C
Gene ID 8794
UniProt O14798
Research Area Signaling, Apoptosis/Necrosis
Pathways Apoptosis
Application Notes ELISA. Western Blot: 0.5 to 1 μg/mL. An approximate 65 kDa band can be detected. Immunofluorescence.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions For Research Use only
Buffer PBS containing 0.02 % sodium azide.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Storage Comment Store the antibody undiluted at 2-8 °C.
Supplier Images
Immunofluorescence (IF) image for anti-TNFRSF10C antibody (Tumor Necrosis Factor Receptor Superfamily, Member 10c, Decoy Without An Intracellular Domain) (ABIN499722) Immunofluorescence of DcR1 in rat liver tissue with AP30279PU-N DcR1 antibody at 10 μ...
Western Blotting (WB) image for anti-TNFRSF10C antibody (Tumor Necrosis Factor Receptor Superfamily, Member 10c, Decoy Without An Intracellular Domain) (ABIN499722) Western blot analysis of DcR1 in HeLa cell (A), mouse (B) and rat (C) liver tissue ly...
Background publications Degli-Esposti, Smolak, Walczak et al.: "Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family." in: The Journal of experimental medicine, Vol. 186, Issue 7, pp. 1165-70, 1997 (PubMed).

Sheridan, Marsters, Pitti et al.: "Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors." in: Science (New York, N.Y.), Vol. 277, Issue 5327, pp. 818-21, 1997 (PubMed).

Pan, Ni, Wei et al.: "An antagonist decoy receptor and a death domain-containing receptor for TRAIL." in: Science (New York, N.Y.), Vol. 277, Issue 5327, pp. 815-8, 1997 (PubMed).

Pan, ORourke, Chinnaiyan et al.: "The receptor for the cytotoxic ligand TRAIL." in: Science (New York, N.Y.), Vol. 276, Issue 5309, pp. 111-3, 1997 (PubMed).

Did you look for something else?